{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:08:23Z","timestamp":1794049703404,"version":"4.8.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.annonc.2020.07.020","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T21:41:44Z","timestamp":1597268504000},"page":"1553-1560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2653-1657","authenticated-orcid":false,"given":"P.","family":"Grimison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mersiades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Lintzeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Olver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tognela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Briscoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aghmesheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Della-Fiorentina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gedye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Begbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Simes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Stockler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annonc.2020.07.020_bib1","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/annonc\/mds021","article-title":"The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)","volume":"23","author":"Aapro","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annonc.2020.07.020_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JOP.2012.000816","article-title":"Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study","volume":"10","author":"Gilmore","year":"2014","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.annonc.2020.07.020_bib3","first-page":"201","article-title":"A\u00a0prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre","volume":"16","author":"Molassiotis","year":"2008","journal-title":"Support Care Cancer"},{"issue":"14","key":"10.1016\/j.annonc.2020.07.020_bib4","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annonc.2020.07.020_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.annonc.2020.07.020_bib6","first-page":"109","article-title":"Medical marijuana for cancer","volume":"65","author":"Kramer","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.annonc.2020.07.020_bib7","first-page":"2095","article-title":"Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting\u2014a systematic review and meta-analysis","volume":"28","author":"Chow","year":"2020","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.annonc.2020.07.020_bib8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamaoncol.2016.0155","article-title":"Medical marijuana use in oncology: a review","volume":"2","author":"Wilkie","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.annonc.2020.07.020_bib9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuro.2019.08.002","article-title":"Cannabidiol (CBD) use in psychiatric disorders: a systematic review","volume":"74","author":"Bonaccorso","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.annonc.2020.07.020_bib10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2125.2010.03743.x","article-title":"Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting","volume":"70","author":"Duran","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.annonc.2020.07.020_bib11","doi-asserted-by":"crossref","first-page":"e020745","DOI":"10.1136\/bmjopen-2017-020745","article-title":"Oral cannabinoid-rich THC:CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)","volume":"8","author":"Mersiades","year":"2018","journal-title":"BMJ Open"},{"issue":"suppl 5","key":"10.1016\/j.annonc.2020.07.020_bib12","doi-asserted-by":"crossref","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"MASCC and ESMO consensus guidelines for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting: ESMO clinical practice guidelines","volume":"27","author":"Roila","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annonc.2020.07.020_bib13","series-title":"MASCC\/ESMO Antiemetic Guideline 2016 with Updates in 2019","author":"Appro","year":"2019"},{"key":"10.1016\/j.annonc.2020.07.020_bib15","first-page":"522","article-title":"Assessing the impact of chemotherapy-induced nausea and vomiting on patients'\u00a0daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall","volume":"11","author":"Martin","year":"2003","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.annonc.2020.07.020_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40271-013-0036-x","article-title":"Validity and reliability of the Assessment of Quality of Life (AQoL)-8D multi-attribute utility instrument","volume":"7","author":"Richardson","year":"2014","journal-title":"Patient"},{"key":"10.1016\/j.annonc.2020.07.020_bib17","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0","year":"2009"},{"issue":"9","key":"10.1016\/j.annonc.2020.07.020_bib18","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jamainternmed.2019.1993","article-title":"Nabiximols for the treatment of cannabis dependence: a randomized clinical trial","volume":"179","author":"Lintzeris","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.annonc.2020.07.020_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1467-842X.2005.tb00063.x","article-title":"Population norms and meaningful differences for the Assessment of Quality of Life AQoL measure","volume":"29","author":"Hawthorne","year":"2005","journal-title":"Aust N Z J Public Health"},{"issue":"8","key":"10.1016\/j.annonc.2020.07.020_bib20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/10826084.2020.1731547","article-title":"What do you know about Maryjane? A systematic review of the current data on the THC:CBD ratio","volume":"55","author":"Zeyl","year":"2020","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.annonc.2020.07.020_bib21","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/bcp.14038","article-title":"A\u00a0systematic review of cannabidiol dosing in clinical populations","volume":"85","author":"Millar","year":"2019","journal-title":"Br J Clin Pharmacol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420399968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420399968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:59:20Z","timestamp":1760335160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420399968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0923753420399968"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2020.07.020","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2020.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Society for Medical Oncology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}